Delivery Order SPE2DB25D9320-SPE2DB26FWEYH
- Not listed
- The Defense Logistics Agency issued a delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Stelara 90 mg/mL syringes. The contract was awarded on October 21, 2025, with an ultimate completion date of November 12, 2025, under a firm fixed-price arrangement with no set-aside designation. This delivery order was issued pursuant to DMS Pharmaceutical Group's Indefinite...
- The Defense Logistics Agency has issued a delivery order valued at approximately $49,752 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. This firm fixed-price delivery order, awarded on October 29, 2025, with an ultimate completion date of November 20, 2025, contains no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $82,920.65 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90mg/mL syringes. This firm fixed-price delivery order, issued on October 24, 2025, represents one of numerous pharmaceutical supply orders placed with DMS Pharmaceutical Group under the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V)...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $7,730.52 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 130 mg/26 mL vials. The delivery order, issued on October 24, 2025, with an ultimate completion date of November 17, 2025, carries no set-aside designation, indicating the vendor competed in unrestricted federal procurement. This award represents one of...
- The Defense Logistics Agency awarded a delivery order valued at approximately $65K to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/mL syringes. This firm fixed-price delivery order, issued on October 30, 2025, with an ultimate completion date of November 21, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The...
- The Defense Logistics Agency's Medical Supply Chain division awarded a $81,249.75 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/mL syringes. The delivery order, issued on October 17, 2025, carries an ultimate completion date of November 7, 2025, and was awarded without a set-aside designation, demonstrating the contractor's competitive capability in...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $33,168.26 by the Defense Logistics Agency for STELARA 90 mg/mL syringes. The award, issued on October 23, 2025, with an ultimate completion date of November 14, 2025, carries no set-aside designation, demonstrating the company's competitive capability in unrestricted federal procurement. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. This firm fixed-price delivery order, issued on October 27, 2025, with an ultimate completion date of November 18, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award is...
- The Defense Logistics Agency issued a delivery order valued at approximately $97.5K to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/mL syringes. This firm fixed-price delivery order, awarded on October 23, 2025, represents a direct purchase without set-aside designation, demonstrating DMS Pharmaceutical Group's competitive capability in unrestricted federal pharmaceutical procurement. The...
- The Defense Logistics Agency awarded a delivery order valued at $16,154.36 to DMS Pharmaceutical Group Inc. for the supply of Stelara 90 mg/ml syringes. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will fulfill this order with an ultimate completion date of October 17, 2025. This delivery order was awarded on a firm fixed-price basis with no set-aside designation, allowing the vendor to compete on an open basis despite its...
- SPE2DB25D9320Indefinite Delivery Contract
- SPE2DB25D9320-SPE2DB26FWEYHDelivery Order
The Defense Logistics Agency awarded a $16,249.95 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for STELARA 90 mg/ml syringes. This delivery order, issued on October 30, 2025, represents a single transaction under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The delivery order carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement, with an ultimate completion date of November 21, 2025. DMS Pharmaceutical Group serves as a critical pharmaceutical supplier within the Department of Defense's medical supply chain, authorized to distribute a comprehensive portfolio of branded and generic prescription medications, biologics, vaccines, and specialty pharmaceuticals to military healthcare facilities worldwide. The vendor's underlying prime vendor contract, awarded on November 13, 2025, carries a $499.999 billion ceiling value through December 31, 2036, positioning the company as a regional supplier within the broader $30.3 billion PPV-G GEN V acquisition strategy designed to modernize and consolidate pharmaceutical supply chain operations across the federal military medical system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.2k | 10/30/25 |